23andme Holding Co Stock EBITDA
| ME Stock | USD 3.11 0.12 3.72% |
23Andme Holding Co fundamentals help investors to digest information that contributes to 23Andme Holding's financial success or failures. It also enables traders to predict the movement of 23Andme Stock. The fundamental analysis module provides a way to measure 23Andme Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 23Andme Holding stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -291.9 M | -306.5 M |
23Andme | EBITDA |
23Andme Holding Co Company EBITDA Analysis
23Andme Holding's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current 23Andme Holding EBITDA | (291.87 M) |
Most of 23Andme Holding's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 23Andme Holding Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
23Andme EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for 23Andme Holding is extremely important. It helps to project a fair market value of 23Andme Stock properly, considering its historical fundamentals such as EBITDA. Since 23Andme Holding's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of 23Andme Holding's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of 23Andme Holding's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
23Andme Ebitda
Ebitda |
|
According to the company disclosure, 23Andme Holding Co reported earnings before interest,tax, depreciation and amortization of (291.87 Million). This is 133.26% lower than that of the Biotechnology sector and 184.14% lower than that of the Health Care industry. The ebitda for all United States stocks is 107.49% higher than that of the company.
23Andme EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 23Andme Holding's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 23Andme Holding could also be used in its relative valuation, which is a method of valuing 23Andme Holding by comparing valuation metrics of similar companies.23Andme Holding is currently under evaluation in ebitda category among its peers.
23Andme Holding ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, 23Andme Holding's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to 23Andme Holding's managers, analysts, and investors.Environmental | Governance | Social |
23Andme Holding Institutional Holders
Institutional Holdings refers to the ownership stake in 23Andme Holding that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of 23Andme Holding's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing 23Andme Holding's value.| Shares | Steel Partners Holdings Lp | 2024-06-30 | 2.1 M | Goldman Sachs Group Inc | 2024-06-30 | 1.9 M | J. Safra Sarasin Holding Ag | 2024-06-30 | 1.9 M | Susquehanna International Group, Llp | 2024-06-30 | 1.8 M | Charles Schwab Investment Management Inc | 2024-06-30 | 1.8 M | State Street Corp | 2024-06-30 | 1.2 M | Amvescap Plc. | 2024-06-30 | 844.1 K | Fmr Inc | 2024-06-30 | 801.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 787.2 K | Newview Capital Partners I, Llc | 2024-06-30 | 19.5 M | Vanguard Group Inc | 2024-06-30 | 15.4 M |
23Andme Fundamentals
| Return On Equity | -1.54 | ||||
| Return On Asset | -0.26 | ||||
| Operating Margin | (1.78) % | ||||
| Current Valuation | 26.31 M | ||||
| Shares Outstanding | 19.01 M | ||||
| Shares Owned By Insiders | 3.65 % | ||||
| Shares Owned By Institutions | 33.33 % | ||||
| Number Of Shares Shorted | 1.2 M | ||||
| Price To Earning | (3.48) X | ||||
| Price To Book | 0.80 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 219.64 M | ||||
| Gross Profit | 132.94 M | ||||
| EBITDA | (291.87 M) | ||||
| Net Income | (666.7 M) | ||||
| Cash And Equivalents | 410.89 M | ||||
| Cash Per Share | 0.90 X | ||||
| Total Debt | 76.52 M | ||||
| Debt To Equity | 0.1 % | ||||
| Current Ratio | 3.49 X | ||||
| Book Value Per Share | 7.69 X | ||||
| Cash Flow From Operations | (164.32 M) | ||||
| Short Ratio | 4.52 X | ||||
| Earnings Per Share | (122.52) X | ||||
| Target Price | 40.0 | ||||
| Number Of Employees | 560 | ||||
| Beta | 1.26 | ||||
| Market Capitalization | 81.23 M | ||||
| Total Asset | 395.17 M | ||||
| Retained Earnings | (2.17 B) | ||||
| Working Capital | 127.98 M | ||||
| Current Asset | 212.32 M | ||||
| Current Liabilities | 372.61 M | ||||
| Net Asset | 395.17 M |
About 23Andme Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 23Andme Holding Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 23Andme Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 23Andme Holding Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out 23Andme Holding Piotroski F Score and 23Andme Holding Altman Z Score analysis. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 23Andme Holding. If investors know 23Andme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 23Andme Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (122.52) | Revenue Per Share 8.224 | Quarterly Revenue Growth (0.34) | Return On Assets (0.26) | Return On Equity (1.54) |
The market value of 23Andme Holding is measured differently than its book value, which is the value of 23Andme that is recorded on the company's balance sheet. Investors also form their own opinion of 23Andme Holding's value that differs from its market value or its book value, called intrinsic value, which is 23Andme Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 23Andme Holding's market value can be influenced by many factors that don't directly affect 23Andme Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 23Andme Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if 23Andme Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 23Andme Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.